Consolidated Statements of Loss (unaudited) - USD ($)	3 Months Ended	6 Months Ended
Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue
Collaborations, milestones, and royalties	$ 16,960,000	$ 45,523,000	$ 29,765,000	$ 64,485,000
Operating expenses
Research and development	61,531,000	60,060,000	118,404,000	125,612,000
General and administrative	17,746,000	11,460,000	31,533,000	25,613,000
Total operating expenses	79,277,000	71,520,000	149,937,000	151,225,000
Loss from operations	(62,317,000)	(25,997,000)	(120,172,000)	(86,740,000)
Other income (expense)
Interest income	7,681,000	3,771,000	16,229,000	6,670,000
Interest expense	(844,000)	(7,000)	(1,921,000)	(14,000)
Other expense, net	(4,000)	(9,000)	(4,000)	(23,000)
Impairment on equity securities	220,000	0	(20,430,000)	0
Gain (loss) on equity securities, net	(12,027,000)	288,000	(9,702,000)	(2,610,000)
Total other income (expense), net	(4,974,000)	4,043,000	(15,828,000)	4,023,000
Loss before income tax expense	(67,291,000)	(21,954,000)	(136,000,000)	(82,717,000)
Income tax expense	117,000	0	117,000	0
Net loss	(67,408,000)	(21,954,000)	(136,117,000)	(82,717,000)
Net loss attributable to non-controlling interest	(1,445,000)	0	(2,121,000)	0
Net loss attributable to Xencor, Inc.	$ (65,963,000)	$ (21,954,000)	$ (133,996,000)	$ (82,717,000)
Basic net loss per common share attributable to Xencor, Inc. (in dollars per share)	$ (1.07)	$ (0.37)	$ (2.18)	$ (1.38)
Diluted net loss per common share attributable to Xencor, Inc. (in dollars per share)	$ (1.07)	$ (0.37)	$ (2.18)	$ (1.38)
Weighted average shares used to compute net income (loss) per share attributable to common stockholders:
Basic weighted average common shares outstanding (in shares)	61,676,444	59,807,558	61,444,384	59,922,784
Diluted weighted average common shares outstanding (in shares)	61,676,444	59,807,558	61,444,384	59,922,784

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.